CORRECTING and REPLACING: Luminati Participates In Covid-19 Task Force Launched To Prevent Virus Spread

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Please replace the release dated March 30, 2020 with the following corrected version due to multiple revisions.

The corrected release reads:


Sprint Covid-19 Initiative Aims To Test Blood Oxygen Levels Through Smart Devices

Sprint Covid-19 is a task force led by the Innovation Department at Assuta Hospital in Ashdod, Israel, together with Rafael Advanced Technology and Weizmann Institute of Science. As part of its planned activities, the team has launched a new initiative with the aim of increasing testing for the Coronavirus through smart devices. As part of its continued work against the virus, Sprint Covid-19 is working to develop a heuristic test that can be carried out on smartphones and smartwatches to identify asymptomatic, presymptomatic and mild cases which would otherwise go undetected.

The task force has set out to enhance large-scale Covid-19 testing, something that is proving a huge challenge for countries around the world. Through technology available on a number of smart devices, Sprint Covid-19 aims to measure users blood oxygen levels, which is seen as an important first step in identifying the virus.

A large percentage of the coronavirus infected population may suffer from silent hypoxemia, i.e. hypoxemia without dyspnea, said Myriam Bocobza who is heading the innovative research. Based on information gathered in Italy we can estimate that 30%-50% of the coronavirus positive carriers did not feel any symptoms, so they kept wandering around infecting more people. We are in the process of confirming these numbers.

In a bid to tackle this issue, we found that many smartphones or smartwatch devices enable testing your own blood oxygen levels and this could lead to identifying new and existing cases. Blood oxygen levels need to be tested as an early indication to help tackle the spread of the virus. said Bocobza.

Tracking and identifying compatible smart devices is a task that requires collecting massive amounts of openly available data from across the worldwide web. In just under 24 hours, Luminati Networks, a leading operator in the data collection automation industry, has processed a huge amount of data locating over 110 smartphone models, 165 models of smartwatches and smart bands, that can conduct this simple test.

We were thrilled that we could help with such a critical task of potentially saving many lives, said Or Lenchner, Luminati Networks, CEO. We continue to offer all relevant researchers from all over the world our expertise in collecting openly available online data for free. We want to help in any way we can.

In order to provide a solution, Sprint Covid-19 needed to know if it is feasible to have a large portion of the population checking their own oxygen blood levels daily and independently using their smartphones or smartwatches. Thankfully through the use of technology and data, this is possible.

In Israel alone, 13% of mobile users that own a Samsung model are able to test oxygen levels in their blood,” said Lenchner. “We also gathered information across the globe and found that up to 17% of the global smartphone owners own devices that carry the Sp02 sensor, which can enable the test as well, covering nearly 19% of the US smartphone owners, 18% of the UK smartphone owners and up to 12% of Italys. These are outstanding numbers and I hope they help in stopping the Covid-19 pandemics progress. he added.

The Covid-19 task force plans to make the list of devices available to the Israeli public and the rest of the world shortly.

Jacob Greenwood

[email protected]